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Abstract
Background: Necrotizing enterocolitis (NEC) is a catastrophic disease of preterm infants, and microbial dysbiosis
has been implicated in its pathogenesis. Studies evaluating the microbiome in NEC and preterm infants lack power
and have reported inconsistent results.
Methods and results: Our objectives were to perform a systematic review and meta-analyses of stool microbiome
profiles in preterm infants to discern and describe microbial dysbiosis prior to the onset of NEC and to
explore heterogeneity among studies. We searched MEDLINE, PubMed, CINAHL, and conference abstracts from the
proceedings of Pediatric Academic Societies and reference lists of relevant identified articles in April 2016. Studies
comparing the intestinal microbiome in preterm infants who developed NEC to those of controls, using culture-
independent molecular techniques and reported α and β-diversity metrics, and microbial profiles were included. In
addition, 16S ribosomal ribonucleic acid (rRNA) sequence data with clinical meta-data were requested from
the authors of included studies or searched in public data repositories. We reprocessed the 16S rRNA sequence data
through a uniform analysis pipeline, which were then synthesized by meta-analysis.
We included 14 studies in this review, and data from eight studies were available for quantitative synthesis (106 NEC
cases, 278 controls, 2944 samples). The age of NEC onset was at a mean ± SD of 30.1 ± 2.4 weeks post-conception
(n = 61). Fecal microbiome from preterm infants with NEC had increased relative abundances of Proteobacteria and
decreased relative abundances of Firmicutes and Bacteroidetes prior to NEC onset. Alpha- or beta-diversity indices in
preterm infants with NEC were not consistently different from controls, but we found differences in taxonomic profiles
related to antibiotic exposure, formula feeding, and mode of delivery. Exploring heterogeneity revealed differences in
microbial profiles by study and the target region of the 16S rRNA gene (V1-V3 or V3-V5).
Conclusions: Microbial dysbiosis preceding NEC in preterm infants is characterized by increased relative abundances
of Proteobacteria and decreased relative abundances of Firmicutes and Bacteroidetes. Microbiome optimization may
provide a novel strategy for preventing NEC.
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Background
Necrotizing enterocolitis (NEC) is a catastrophic disease
that is a major cause of mortality in preterm infants who
survive the first few days after birth [1]. NEC occurs in
7% of infants born at less than 1500 g and up to 5% of
admissions to the neonatal intensive care unit [2–5].
NEC is associated with a high mortality (15–30%) and
long-term neurodevelopmental morbidity [2, 6].
The pathogenesis of NEC is not clear, and a unifying
concept is lacking but microbial dysbiosis, formula feed-
ing, and excessive inflammation have all been implicated
[2, 7–9]. Compared to term infants, the intestinal micro-
biota of preterm infants has fewer bacterial species, less
diversity, and increased proportions of potential patho-
gens [10, 11]. The microbial dysbiosis hypothesis of NEC
is supported by the fact that NEC cannot be produced in
germ free animals [12, 13] and by an association
between early antibiotic use and NEC [14, 15]. Immune
dysregulation in association with microbial dysbiosis
including excessive toll-like receptor 4 (TLR4) signaling
in response to lipopolysaccharide (LPS) [12, 16–18] and
an exaggerated inflammatory response [8, 9] have been
reported, but these are largely animal data.
Technological advances and availability of new mo-
lecular and analytic techniques such as those used in
Human Microbiome Project [19, 20] have provided
greater resolution in the evaluation of the neonatal intes-
tinal microbiome. Most studies on the human micro-
biome do not have sufficient power to detect clinically
important differences [21]. Previously reported micro-
biome studies on NEC in preterm infants may have been
underpowered to detect differences and have reported
inconsistent results. We systematically reviewed studies
that reported the intestinal microbiome in preterm
infants who developed NEC in relation to controls and
performed a meta-analysis of 16S ribosomal ribonucleic
acid (rRNA) gene sequence data from eight of the
included studies. To our knowledge, this is the first
systematic review and meta-analysis of microbiome
studies on NEC in preterm infants.
Objectives
The primary objective of this review is to determine and
describe intestinal microbial dysbiosis patterns in preterm
infants preceding NEC (defined as stage II or stage III of
Bell’s classification [22]). The secondary objective is to
explore heterogeneity among studies that might explain
inconsistency in the reported results.
Methods
We performed our systematic review according to the
recommended “Preferred Reporting Items for Systematic
Reviews and Meta-analyses” (PRISMA) guidelines [23] and
“Meta-analysis of Observational Studies in Epidemiology”
(MOOSE) consensus statement [24]. We followed previ-
ously published methods for the meta-analyses of micro-
biome data [25].
Inclusion criteria
Prospective or retrospective, case-control or cohort
studies were included if they evaluated the neonatal
intestinal microbiome in preterm infants with NEC
compared to those infants without NEC, using culture-
independent molecular techniques and reported α and
β-diversity metrics and microbial profiles.
We searched for eligible studies using the Cochrane
Neonatal Review Group’s (CNRG) search strategy (http://
neonatal.cochrane.org/) without language restriction in
April 2016. Search strategy and databases searched are
outlined in Additional file 1.
Data collection and analyses
All titles and abstracts identified by our search strategy
were screened for relevance by MP, and those deemed
relevant were retrieved in full and evaluated for inclu-
sion eligibility by MP and JN independently. All results
were compared, and disagreements were resolved by
mutual discussion. Relevant data were extracted from
included studies and additional information to clarify
the study design, and data was sought from the authors
via email, for at least three attempts. The data extracted
by the author were discussed for any discrepancies by
input from a second author JN, and any conflicts were
resolved by mutual discussion. In addition, 16S rRNA
gene sequence data with clinical meta-data were
requested from the principal investigators of the published
studies. The methodological quality of each study was
assessed using relevant items of the checklist proposed for
observational studies by Viswanathan et al. [26].
Meta-analysis of microbiome data
We compiled all sequence files and subject phenotype
data received from the investigators or downloaded from
the National Center for Biotechnology Information
Short Read Archive (NCBI SRA), Database of Genotypes
and Phenotypes (NCBI dbGaP), and/or the European
Nucleotide Archive (ENA) (accessed 06/27/2015). All
sequences were processed using Quantitative Insights
into Microbial Ecology package (QIIME 1.8.0) [25, 27].
Quality parameters of ≥25 average quality score,
200–1000 base length, no mismatches to barcode and
primer, primer removal, no ambiguous bases, and
maximum homopolymer length of 8 were used. As there
were several 16S variable regions targeted, operational
taxonomic units (OTUs) were assigned by closed-
reference picking against the GreenGenes v13_8 database
with the UCLUST algorithm in QIIME [28, 29]. We
removed all samples that failed to yield at least 1200
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sequences, resulting in the exclusion of one complete
study [30] due to shallow sequencing depth. All analyses
were performed on the rarefied data.
We derived the corrected gestational age (CGA) at
diagnosis of NEC by adding gestational age at birth to
the day of diagnosis of NEC for 61 individual cases of
NEC. The distribution of NEC diagnoses in CGA
(weeks) was tested for a continuous normal distribution
with the Shapiro-Wilk method.
QIIME was used to calculate alpha diversity metrics, in-
cluding observed OTUs, and the Shannon and Simpson
diversity indices. Differences in alpha diversity metrics
were tested with Mann-Whitney or Kruskal-Wallis
tests, depending on the number of groups being com-
pared, and Dunn’s multiple comparison testing was
implemented for those with significant differences.
We also utilized a negative binomial regression model
to evaluate the degree to which number of species
(our dependent variable) could be explained by gestational
age, group (NEC vs. control), and a gestational age by
group interaction term.
The weighted and unweighted UniFrac metrics were
used for beta diversity comparisons. Differences in
taxonomic relative abundance were evaluated with Mann-
Whitney or Kruskal-Wallis tests and Benjamini-Hochberg
false discovery rate correction.
Results
Our search identified 6812 records. After removing
duplicate reports, we screened 4217 records for inclu-
sion and excluded 4193 records (PRISMA flow diagram,
Fig. 1). Of the 24 full text articles reviewed for eligibility,
14 studies met our inclusion criteria. Ten excluded
studies and reasons for exclusion are summarized in
Table 1. Methodological quality of the 14 included studies
was assessed using the item checklist and responses as
“yes”, “no,” or “unclear” are reported in Table 2. The
microbiota characteristics reported by the 14 included
studies including alpha and beta diversity indices and
microbial profiles are summarized in Additional file 2. It
should be noted that when evaluating diversity in a non-
complex microbial population, shifts may be attributed to
one or few bacterial taxa. As such, differences in diversity
may serve as a proxy for overrepresentation or underrep-
resentation of small number of organisms and are
discussed later in the paper.
Fig. 1 PRISMA flow diagram depicts our search results and selection of included studies in this systematic review
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Results of the meta-analyses
Nine of 14 studies included in the systematic review pro-
vided sequence and clinical metadata for both the NEC
cases and control patients. Data from one study [30] was
excluded due to shallow sequencing depth, and hence,
data from eight studies were incorporated in our quanti-
tative synthesis (106 NEC cases, 278 controls, 2944
samples) [31–38] (Additional file 3). The results of the
systematic review and meta-analysis are reported as
recommened by PRISMA guidelines (Additional file 4).
Microbiome profile differences between NEC and controls
Corrected gestational age CGA at NEC diagnosis in
preterm infants forms a normal distribution (n = 61, a
subset of the population, Shapiro-Wilk test, p = 0.26)
with a mean ± SD of 30.1 ± 2.4 weeks (median, 30 weeks)
post-conception (Fig. 2). We analyzed data from samples
collected at all CGAs and compared alpha-diversity
metrics between infants with NEC and controls
(Additional file 5). None of the alpha-diversity metrics
calculated differed significantly between infants with NEC
and controls (Fig. 3a–c). When alpha-diversity metrics
(means of OTU richness and SDI) were plotted over
CGA, we found that in control infants, OTU richness and
SDI decreased from birth to their lowest level at about a
CGA of 27 weeks and gradually increased to 36 weeks
CGA (Additional file 6: Fig. S1a, b). The results of our
negative binomial regression modeling support this
pattern, indicating that the number of species increased
significantly with gestational age (p < 0.001) and that NEC
patients tended to have fewer species than controls after
controlling for gestational age (p = 0.053). Principal
coordinates analysis (PCoA) with the UniFrac metrics
did not show clustering of samples as a function of
NEC vs. control status (Fig. 3d, e).
Taxonomic abundances grouped by CGA showed
consistent trends toward increased relative abundances
of Proteobacteria and decreased relative abundances of
Firmicutes and Bacteroidetes in infants with NEC, which
contrasted with decreased relative abundances of Proteo-
bacteria and increased abundances of Firmicutes
observed in control infants (Fig. 4). Of note, this devi-
ation in taxonomic abundances in preterm infants with
NEC vs. controls happens around 30 weeks CGA
(Fig. 4a), which was the mean and median age of onset
of NEC in preterm infants in this pooled cohort. When
examined at all CGAs, significant differences were
observed with respect to the relative abundances of
Proteobacteria, Firmicutes, and Bacteroidetes (Fig. 4b–d).
Differences in the relative abundance of bacterial phyla
and genera in NEC infants vs. controls are depicted in
Fig. 4e, f, respectively.
Comparison of microbiota profiles between infants who
had NEC compared to controls in relation to antibiotic
exposure, diet, and mode of delivery
Investigating antibiotic exposure, which was defined
inconsistently among the different studies (samples
analyzed; controls with antibiotics n = 1822, controls
without antibiotics, n = 107, NEC infants with antibiotics
n = 273, and NEC infants without antibiotics, n = 29),
OTU richness and SDI differed significantly between
control infants who did not receive antibiotics compared
to NEC infants who received antibiotics. OTU richness
was significantly different between control infants with
and without antibiotics, as was SDI between control
infants with antibiotics and NEC infants with antibiotics
(Additional file 7: Fig. S2a, b). PCoA by antibiotic ex-
posure demonstrated clustering by the weighted and
unweighted UniFrac metrics (Additional file 7: Fig. S2c, d).
In conjunction with antibiotic exposure, we observed in
control and NEC infants, increased relative abundances of
Proteobacteria, and decreased relative abundances of Firmi-
cutes, Actinobacteria, and Bacteroidetes. Among control
infants, antibiotic exposure was associated with increased
relative abundances of Klebsiella, unclassified Enterobacte-
riaceae, Proteus, Paenibacillus, Epulopiscium, and Pseudo-
monas at the genus level. Control infants not exposed
to antibiotics had increased abundances of the
genus Clostridium and unclassified Clostridiaceae
(Additional file 7: Fig. S2e, f ).
Table 1 Table of excluded studies
Study Reason for exclusion
Schwiertz 2003 [57] A study of 29 preterm infants by
PCR-DGGE analysis of which only
one case of NEC was observed.
No comparison of NEC and controls.
Bjorkstorm 2009 [58] Only stool cultures and fecal
calprotectin were measured.
LaTuga 2011 [59] A study of eleven ELBW infants was
excluded as there were no direct
comparison of NEC and controls.
Morowitz 2011 [49] Community genomic analysis at the
strain level in one premature infant
was excluded because the study
did not compare NEC and controls.
Sharon 2013 [60] Time shifts in community genomics
was excluded because the study
did not compare NEC and controls.
Carlisle 2013 [10] A review was excluded.
Grishin 2013 [61] A review was excluded.
Torraza 2013 [56] A review was excluded.
Taft 2014 [55] Description of the microbiome
in preterm infants without NEC
or sepsis and not a comparison
of NEC with controls.
Raveh-Sadka 2015 [62] Not a comparison of NEC with
controls.
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Investigating the role of diet (i.e., breast milk, formula,
or both) (samples analyzed, breast milk-fed controls
n = 967, formula-fed controls n = 55, both breast milk-
and formula-fed controls n = 1300; breast milk-fed
NEC n = 251, formula-fed NEC n = 15, both breast milk-
and formula-fed NEC n = 241), significant differences in
OTU richness but not SDI were observed between control
breast milk-fed infants vs. NEC breast milk-fed infants
and control subjects receiving breast milk vs. both breast
milk and formula (Additional file 8: Fig. 3a, b). Meaningful
clustering as a function of diet was not observed on PCoA
plots (Additional file 8: Fig. S3c, d). Among control
infants, we observed increased relative abundances of the
phylum Firmicutes and decreased abundances of Proteo-
bacteria in formula-fed infants compared to breast milk
fed-infants (Additional file 8: Fig. S3e, f ). Formula-fed
babies who developed NEC had more Proteobacteria and
less Firmicutes compared to breast milk-fed controls.
Investigating the role of mode of delivery (samples
analyzed, vaginal delivery; control n = 683, NEC n = 178;
C-section; control n = 1618, NEC n = 350), we found no
differences in OTU richness or SDI betweeen NEC and
Fig. 2 Histogram of necrotizing enterocolitis (NEC) cases by weeks
corrected gestational age (CGA). The distribution of 61 cases of NEC
plotted against CGA at the time of diagnosis is normal (Shapiro-Wilk
test, p = 0.26). The mean ± SD, CGA at the time of NEC diagnosis
was 30.1 ± 2.4 weeks.
Fig. 3 Alpha and beta diversity-NEC vs. controls. Alpha-diversity comparison for all corrected gestational ages (CGA) by NEC case vs. control by three
metrics. a Observed species, b Shannon diversity, and c Simpson diversity, none of the comparisons are significantly different. Data is represented in
box and whisker plots with median and whiskers representing 10–90th centiles. Principal co-ordinate (PCoA) plots of weighted UniFrac distance (d) and
unweighted UniFrac distance (e) including all time points from all studies shows a lack of clustering between cases and controls. The
figure in parenthesis next the axis labels represents the proportion of variation explained along each axis. Orange circles represent samples from preterm
infants with NEC, and green triangles represent samples from control preterm infants
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controls but observed significant differences between
control infants born by vaginal delivery compared to
cesarean-section delivery (Additional file 9: Fig. S4a, b).
No clustering was observed by mode of delivery on
PCoA plots (Additional file 9: Fig. S4c, d). In control in-
fants, we found increased relative abundance of the
Fig. 4 Comparison of taxonomic profiles between infants with necrotizing enterocolitis (NEC) and controls. a NEC infants had trends of increased
relative abundance in Proteobacteria from 24 to 36 weeks corrected gestational age (CGA) accompanied by decreased abundances in Firmicutes
and Bacteroidetes, relative to controls. In control infants, the relative abundance of Proteobacteria decreased after 27 weeks and coincided with an
increase in Firmicutes and Bacteroidetes. b–d Phylum level differences between NEC cases and controls across CGA (data in means and SD) showed
significant differences in Proteobacteria, Firmicutes, and Bacteroidetes (*p < 0.05). e, f Mean relative abundance distributions between NEC cases and
controls at the phylum level (e) and genus level (f) when data from all CGAs are included
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phylum Firmicutes in infants born by cesarean section
and increased abundance of Bacteroidetes in infants
born via vaginal delivery (Additional file 9: Fig. S4e, d).
Heterogeneity among included studies
Three studies in our meta-analysis targeted the V1-
V3 region of the 16S rRNA gene, and five studies
targeted the V3-V5 region. There were no differences
in alpha-diversity metrics (OTU richness or SDI), nor
was meaningful clustering observed within PCoA
plots of UniFrac distances, as a function of variable
region (Fig. 5a–d). In addition, studies targeting the
V3-V5 region compared to the V1-V3 region
reported increased relative abundances of Proteobac-
teria and decreased relative abundances of Firmicutes
(Fig. 5e).
Fig. 5 Heterogeneity assessment by 16S rRNA target region. Observed species (operational taxonomic unit, OTU) richness (a) and Shannon diversity
index (SDI) values (b) in cases and controls are subgrouped by 16S rRNA target region (V1-V3 vs. V3-V5). Data is represented in box and whisker plots
with median and whiskers representing 10–90th centiles. Significant differences were observed in SDI between controls of V1-V3 compared to controls
of V3-V5 (*p < 0.05) and controls of V1-V3 compared to NEC V3-V5. No other significant differences were observed. c, d Depict weighted
and unweighted UniFrac distances in PCoA plots of NEC and controls subgrouped 16S rRNA target region (V1-V3 vs V3-V5), and notable
clustering was observed. The proportion of variation explained along each axis is listed in parenthesis with the axis labels. e Represents
differences in proportion of sequences based on 16S rRNA target regions; V3-V5 targeting resulted in a significant increase in proportion
of sequences of Proteobacteria and significant decrease in proportion of sequences of Firmicutes compared to studies targeting V1-V3.
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We did not find significant differences in alpha diver-
sity among studies although some variations were noted
(Fig. 6a, b), and some clustering as a function of study
was observed on PCoA plots of UniFrac distances
(Fig. 6c, d). NEC samples from studies by Normann et
al. (targeting V3-V5) and Torraza et al. (targeting V1-V3)
had significantly increased relative abundance of the
phylum Firmicutes and significantly decreased relative
abundance of the phylum Proteobacteria compared to
other studies (Fig. 6e).
Discussion
Our review identified 14 eligible studies of which data
from eight studies were synthesized by meta-analysis.
Fig. 6 Heterogeneity assessment by study. Observed species (operational taxonomic unit, OTU) richness (a) and Shannon diversity index (SDI)
values (b) in cases and controls are subgrouped by study. Data is represented in box and whisker plots with median and whiskers representing
10–90th centiles. c, d Depict weighted and unweighted UniFrac distances in PCoA plots of NEC and controls subgrouped by study, and no
notable clustering was observed. The proportion of variation explained along each axis is listed in parenthesis with the axis labels. e Represents
differences in proportion of sequences based on study. Studies by Normann [34] and Torraza [56] showed significant increase in proportion of
sequences of Firmicutes and significant decrease in proportion of sequences of Proteobacteria compared to other studies (*p < 0.05)
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We assessed the methodological quality and risk of bias
in the 14 included studies by the key components of
study design, which has been deemed to be more
important than assigning quality scores in observational
studies [24]. The methodological quality of the included
observational studies was adequate [26]. All studies had
appropriate comparison groups, reported all our pre-
specified outcomes, and results were plausible given the
study limitations. Few studies evaluated outcomes in a
subset of participants. Eleven out of 14 included studies
addressed the issue of confounding by matching or
stratification to avoid known confounders.
Alpha-diversity metrics reported by the included studies
were inconsistent. Three studies reported a decrease in
alpha diversity in preterm infants with NEC compared to
controls [11, 32, 37], one study reported decreasing trends
[33] and others did not report differences [31, 34, 36].
One study [38] included mixed models predicting
Shannon diversity and controlling for gestational age
at birth, route of delivery, and birth weight. Significant
time-associated trends were identified among control
subjects, which increased with respect to diversity over
time, while NEC cases did not. Significant differences in
beta-diversity metrics between NEC cases, and controls
were reported by six studies, two of which were
fingerprinting-based [39, 40] and four were based on
sequencing small pools of PCR amplification prod-
ucts [11, 31, 33, 36].
Reported microbial profiles preceding NEC in preterm
infants were variable across the 14 included studies.
Eight of the 14 studies report an increase in the relative
abundance of the phylum Proteobacteria (class Gamma-
proteobacteria or family Enterobacteriaceae) in the
stools of infants who developed NEC [11, 30, 31, 33–37].
Various studies reported an increased relative abundance
of Gammaproteobacteria and a decrease in other bacterial
species [11], increased relative abundances of Enterococcus
spp. and Citrobacter-like sequences [30], increased relative
abundances of Proteobacteria, or a decreased relative
abundance of Firmicutes in stools before NEC diagnosis
[31]. Increased relative abundances of Proteobacteria two
weeks before and Actinobacteria 1 week before NEC
diagnosis as well as lower counts of Bifidobacteria and
Bacteriodetes have also been observed [36]. Morrow et al.
reported two types of intestinal dysbiosis associated with
NEC [33]; one was dominated by Firmicutes and the other
by Proteobacteria, specifically Enterobacteriaceae. All
NEC cases in the fore-mentioned study lacked Propioni-
bacterium. Some studies reported the abundance of
Clostridium perfringens [35, 37, 39] in the stools of
neonates with NEC, but one study reported the absence of
Clostridia in association with NEC [32]. Three studies
reported unique OTUs in preterm infants with NEC: a
unique bacterial OTU belonging to the Enterobacteriaceae
family [31] and in the first stool samples, the presence of a
novel sequence closest to Klebsiella pneumoniae [36]. In
our pooled meta-analysis, we found that decreased abun-
dances of Firmicutes and Bacteroidetes and increased
abundances of Proteobacteria precede the diagnosis of
NEC in preterm infants.
We synthesized high-quality data available from eight
studies in a sequence-based meta-analysis. The mean
CGA at NEC diagnosis (n = 61) was 30.1 ± 2.4 weeks
(median of 30 weeks). The Canadian network study
suggested a bimodal distribution for the onset of NEC in
preterm infants with an early onset and a late onset
NEC [41]. NEC occurred later after birth in infants born
at younger gestational ages and earlier after birth in
infants born at later gestational ages. Other investigators
report a distribution for the onset of NEC in preterm
infants similar to our findings [38, 42, 43]. We observed
patterns of increased OTU richness over time where the
number of species increased significantly with gesta-
tional age. This may represent the transition beyond the
perinatally acquired microbiome which may be influ-
enced by mode of delivery, the NICU environment,
feeding, antibiotic exposure, or other factors and
warrants further study.
A patterned progression of the intestinal microbiome
has been observed in preterm infants [44]. In a study of
922 16S rRNA sequence libraries from 58 infants, a
patterned progression of bacterial classes from Bacilli to
Gammaproteobacteria and then to Clostridia was
described, and by CGA 33–36 weeks, the communities
were well populated by anaerobes [44]. We were unable
to demonstrate this patterned progression in our meta-
analysis due to lack of associated meta-data in some
studies. In our meta-analyses, we found gradual shifts in
the relative abundances of multiple phyla at about 27 weeks
CGA, where decreased abundances of Firmicutes and
Bacteroidetes and increased abundances of Proteobacteria
precede the diagnosis of NEC in preterm infants. Proteo-
bacteria are recognized by the innate immune system by
TLR4 in the intestine, which may play a significant role in
intestinal inflammation, enterocyte injury that may lead to
the development of NEC in preterm infants [18]. TLR4
expression is increased in the intestinal tract of pre-
term neonates and may regulate the balance between
intestinal repair and injury [12]. It is interesting to
note that TLR4 mutant mice and TLR4 knock out
mice are protected from NEC [17, 45–47], and inhib-
ition of the TLR4 pathway may provide novel
strategies in the treatment or prevention of NEC.
Our sequence-based analysis portrayed inconsistent
differences in SDI, OTU richness, and Simpson diversity
index between NEC cases and controls. Comparison of
species richness over time found that when controlling
for corrected gestational, NEC patients tended to have
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fewer species than controls (p = 0.053, negative binomial
regression model). The absence of consistent differences
with respect to alpha diversity may be due to the low
starting point of microbial diversity that is observed in
preterm infants, relatively small sample sizes in each of
the included studies, or variability with respect to meth-
odology for generating microbiome data. Of particular
concern are the limited numbers of taxa present in
preterm stool. This limitation places constraints on
interpreting diversity changes as diversity in a non-complex
population could reflect changes in only one taxon.
We did not observe distinct clustering of NEC and
control samples by unweighted or weighted UniFrac
metrics. The lack of consistency in distinct clustering of
cases and controls may be due to the methodological,
clinical, or study heterogeneity of the included studies.
We found a consistent trend toward increased relative
abundances of Proteobacteria and decreased in the
relative abundances of Firmicutes and Bacteroidetes pre-
ceding NEC. This is consistent with the predominance
of Proteobacteria in NEC infants reported in some stud-
ies [11, 31, 33, 36]. Although the pooling of data across
studies increased sample size to give statistical power to
detect differences, this benefit may have been out-
weighed by variation with respect to sampling and lab-
based methodology (e.g., sample handling, storage, or
DNA extraction method) associated with the different
studies. Although no single genus or bacterium appears
to cause or precede NEC, increased relative abundances
of Proteobacteria appear to be consistent with NEC-
associated dysbiosis. A recent study that studied fecal
microbiome in preterm and term infants by shotgun
metagenomic sequencing has reported association with
uropathogenic Escherichia coli colonization and necro-
tizing enterocolitis [48], though this study was unusual
in the predominance of E. coli among NEC cases. The
clinical significance of the differences in phyla and
genera between cases and controls of the pooled data
clearly needs further scrutiny. If dysbiosis with increased
Proteobacteria and decreased Firmicutes and Bacteroi-
detes is associated with NEC in preterm infants, then
measures to balance these taxa by probiotic therapy
or luminal antibiotics such as aminoglycosides may be
beneficial.
We report our bacterial data at the taxonomic depth
of phylum. However, we cannot state with certainty if
phylum is the appropriate level to conduct these
analyses. If the inciting mechanism is a shared pheno-
type across all genera within the class, then attempts to
further refine an etiology (or protective group of
bacteria) to a specific genus, species, clade, or genotype
would obscure associations. Alternatively, identification
of important strain level differences have been reported,
which analyses focusing on higher taxonomic levels
would overlook [33, 49]. Indeed, Warner et al. have been
able to identify risk-associated populations at the class
level (Gammaproteobacteria) and protection-associated
populations at the genus level (the members of the
putatively protective Negativicutes class were overwhelm-
ingly Veillonella)[38]. We look forward to continuing
analysis of these data sets and, in additional cohorts, in
future attempts to confirm or refute the associations we
identify and to identify injurious or protective microbes
more narrowly, if possible.
We examined clinical determinants that are known to
affect the developing intestinal microbiome, namely,
antibiotic exposure preceding NEC, mode of delivery,
and diet. We observed differences in the microbial
profiles in the preterm infants who had antibiotics (any
antibiotic) prior to the onset of NEC and found
increased relative abundances of Proteobacteria and
decreased relative abundances of Firmicutes and Actino-
bacteria. This may coincide with the proteobacterial
bloom preceding NEC [11, 31, 33, 36]. Our observations
support the results of studies that report association
of prior antibiotic use with increased incidence of
NEC [14, 15, 50], though we were not able to take
into account various classes of antibiotics, which have
been reported to be determinants of intra-gut bacter-
ial community structure [51]. We also sought taxo-
nomic differences by mode of delivery (cesarean
section or vaginal delivery) and found no differences
in NEC infants but observed increased relative abun-
dances of Firmicutes after cesarean section and
increased relative abundances of Bacteroides after
vaginal delivery in control infants. We also assessed
taxonomic profiles of fecal microbiota based on type
of feeding (breast milk, formula, or both). We found
no differences in NEC infants but observed an
increased relative abundance of Firmicutes in infant-fed
formula compared to breast milk and an increased
relative abundance of Proteobacteria in those fed
breast milk compared to formula (controls). We iden-
tified no significant associations of mode of delivery
or type of feeding with the microbial profiles of
preterm infants who developed NEC.
We also investigated for potential sources of hetero-
geneity in the studies with respect to the variable region
of the 16S rRNA gene targeted (V1-V3 vs. V3-V5) and
by study and did observe differences in alpha-diversity
metrics and UniFrac distances with respect to study and
16S rRNA target regions. Proteobacteria were more
abundant and Firmicutes less abundant in studies target-
ing V3-V5 compared to V1-V3. NEC samples from
studies by Normann et al. (targeting V3-V5) and
Torraza et al. (targeting V1-V3) had significantly
greater relative abundances of the phylum Firmicutes
and significantly decreased relative abundances of the
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phylum Proteobacteria compared to other studies. It
is widely recognized that the use of partial 16S rRNA
gene sequences instead of the whole gene, or whole
genome, can give rise to inconsistencies in evaluating
microbiota composition. Primer bias may influence
which members of the microbial community are
amplified and detected, and OTU counts arising from
different 16S rRNA gene regions can be inconsistent,
challenging interpretation and, to some degree, limiting
consensus with respect to which region best reflects the
gut microbial community. Indeed, investigators have
reported somewhat differing composition and varying
phylogenetic divergence [52, 53]when multiple hyper-
variable regions were sequenced on the same samples
simultaneously, leading to differential detection of
members of Prevotella, Fusobacterium, Eubacterium,
Enterococcus, Streptococcus, Granulicatella, Bacteroides,
Porphyromonas, and Treponema [54, 55].
These studies were performed in different locations
and hospitals, and recent studies have highlighted the
role of geographical differences in the intestinal micro-
biota of preterm infants [55]. We were unable to explore
heterogeneity resulting from differences in DNA extrac-
tion protocols and sample processing methods due to
considerable variation in included studies. The methodo-
logical variations were too great to provide statistical
power for reasonable conclusions.
Strengths and limitations of the review
We adhered to the standard methods of conducting a
systematic review as per recommended guidelines [23,
24]. We searched comprehensively for all eligible studies
using clinically relevant inclusion criteria and strove to
explain sources of heterogeneity by careful analysis of
the study methods and reporting subgroup analyses.
Unlike meta-analyses of randomized control trials,
heterogeneity is a well-recognized problem in reviews of
observational studies [24]. Publication bias in studies
reporting negative results may have excluded eligible
unpublished studies. Poor reporting of study design,
method of enrollment, and patient characteristics may
hamper methodological assessment and external validity
of the studies. The inconsistency in the microbiome
profiles in the stools preceding NEC may be due to con-
siderable clinical and methodological heterogeneity
among the studies. In addition, while metadata was
derived from both NCBI dbGaP as well as from investi-
gators individually, not all metadata could be standardized
and/or be available for incorporation into this analysis.
The other reasons for inconsistency of results among
studies may be differences in location emphasizing the
importance of the unique NICU environment and associ-
ated infection control practices [55] and differences in
time periods of study. We were not able to determine the
time to event (NEC) analysis due to unavailability of day
of NEC diagnosis from the meta-data. The time to event
analysis may have enabled us to describe pre-NEC
changes in microbiome more accurately.
Although there are many narrative reviews, to our
knowledge, this is the first systematic review and meta-
analysis of microbial dysbiosis preceding NEC. Our
review supports the hypothesis that intestinal dysbiosis
with an increase in microbes found primarily within the
phylum Proteobacteria and a decrease in Firmicutes and
Bacteroidetes precedes NEC in preterm infants. Further-
more, antibiotic usage is associated with increased
abundance of Proteobacteria, which is also associated
with higher incidence of NEC. In contrast, increased
Proteobacteria were associated with intake of breast milk
but type of feeding did not associate with development
of NEC. The relationship between Proteobacteria and
NEC seen in our review supports a strong association
but should be viewed in the context of considerable
variations in clinical and methodological characteristics
of included studies. This certainly highlights the need
for standardization of methods and transparent report-
ing of microbiome studies to advance this field. Our data
with its limitations supports the microbial dysbiosis
theory for the development of NEC but also highlights
the lack of host response data to complete the story.
Studies supporting a biologic plausibility will need to
include metagenomics, transcriptomics, and additional
data on inflammatory mediators. Proof of causality will
need to further fulfill Koch’s postulates by recapitulating
certain aspects of the disease in model systems. 16S
rRNA gene sequencing often limits resolution to the
level of the genus, whereas metagenomic data from
whole genome shotgun sequencing may provide reso-
lution at the strain level. Metagenomic analysis and
metabolomics may reveal the differences in the function-
ality of the microbiome in patients who develop NEC.
Optimizing the microbiome and correcting the microbial
profile perturbations by microbial biotherapy may
prevent NEC and improve clinical outcomes.
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with the axis labels. Figs. e and f represent mean relative abundances of
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OTU) richness (A) and Shannon diversity index (SDI) values (B) in cases and
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The proportion of variation explained along each axis is listed in parenthesis
with the axis labels. Figs. e and f represent mean relative abundance
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infants subgrouped by mode of delivery. Observed species (operational
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